← Scroll for more →
Sarepta Therapeutics, Inc. (SRPT)
Pharmaceutical Preparations
Latest Price
$18.62
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
14.47
P/B Ratio
1.29
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18.99M | $341.0M | 17.98% | +4.24M | 2026-06-30 |
| State Street Corp | 8.92M | $160.0M | 8.44% | +2.30M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 8.38M | $150.0M | 7.93% | +1.74M | 2026-06-30 |
| Two Sigma Investments, LP | 4.60M | $82.0M | 4.35% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 4.59M | $82.0M | 4.35% | +13.5K | 2026-06-30 |
| First Trust Advisors LP | 4.37M | $78.0M | 4.13% | +230.2K | 2026-06-30 |
| AQR Capital Management LLC | 4.33M | $76.0M | 4.10% | -2.11M | 2026-06-30 |
| Geode Capital Management, LLC | 2.77M | $49.0M | 2.62% | +783.0K | 2026-06-30 |
| Erste Asset Management GmbH | 2.57M | $45.0M | 2.43% | -400.0K | 2026-06-30 |
| Marshall Wace, LLP | 2.21M | $39.0M | 2.09% | +1.48M | 2026-06-30 |